111 Inc - Asset Resilience Ratio
111 Inc (YI) has an Asset Resilience Ratio of 2.27% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 111 Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how 111 Inc's Asset Resilience Ratio has changed over time. See YI net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down 111 Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 111 Inc stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $50.06 Million | 2.27% |
| Total Liquid Assets | $50.06 Million | 2.27% |
Asset Resilience Insights
- Limited Liquidity: 111 Inc maintains only 2.27% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
111 Inc Industry Peers by Asset Resilience Ratio
Compare 111 Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
China National Medicines Corp Ltd
SHG:600511 |
Medical Distribution | 0.04% |
|
Cyclopharm Ltd
AU:CYC |
Medical Distribution | 1.98% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.21% |
Annual Asset Resilience Ratio for 111 Inc (2016–2025)
The table below shows the annual Asset Resilience Ratio data for 111 Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.27% | $50.06 Million | $2.20 Billion | -- |
| 2024-12-31 | 0.00% | $0.00 | $2.79 Billion | -- |
| 2023-12-31 | 1.62% | $50.14 Million | $3.09 Billion | -4.30pp |
| 2022-12-31 | 5.93% | $205.86 Million | $3.47 Billion | +0.12pp |
| 2021-12-31 | 5.80% | $182.56 Million | $3.15 Billion | -4.11pp |
| 2020-12-31 | 9.92% | $300.17 Million | $3.03 Billion | -- |
| 2019-12-31 | 0.00% | $0.00 | $1.61 Billion | -- |
| 2018-12-31 | 16.35% | $252.81 Million | $1.55 Billion | -22.10pp |
| 2017-12-31 | 38.45% | $293.53 Million | $763.38 Million | +10.11pp |
| 2016-12-31 | 28.34% | $266.82 Million | $941.61 Million | -- |
About 111 Inc
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education,… Read more